485 related articles for article (PubMed ID: 17445753)
1. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities.
Ruigómez A; García Rodríguez LA; Panés J
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):465-9. PubMed ID: 17445753
[TBL] [Abstract][Full Text] [Related]
2. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease.
García Rodríguez LA; Ruigómez A; Panés J
Gastroenterology; 2006 May; 130(6):1588-94. PubMed ID: 16697722
[TBL] [Abstract][Full Text] [Related]
3. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen.
Marshall JK; Thabane M; Borgaonkar MR; James C
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):457-60. PubMed ID: 17289440
[TBL] [Abstract][Full Text] [Related]
4. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak.
Zanini B; Ricci C; Bandera F; Caselani F; Magni A; Laronga AM; Lanzini A;
Am J Gastroenterol; 2012 Jun; 107(6):891-9. PubMed ID: 22525306
[TBL] [Abstract][Full Text] [Related]
5. The clinical course of postinfectious irritable bowel syndrome: a five-year follow-up study.
Jung IS; Kim HS; Park H; Lee SI
J Clin Gastroenterol; 2009 Jul; 43(6):534-40. PubMed ID: 19262407
[TBL] [Abstract][Full Text] [Related]
6. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.
Gradel KO; Nielsen HL; Schønheyder HC; Ejlertsen T; Kristensen B; Nielsen H
Gastroenterology; 2009 Aug; 137(2):495-501. PubMed ID: 19361507
[TBL] [Abstract][Full Text] [Related]
7. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal symptoms after infectious diarrhea: a five-year follow-up in a Swedish cohort of adults.
Törnblom H; Holmvall P; Svenungsson B; Lindberg G
Clin Gastroenterol Hepatol; 2007 Apr; 5(4):461-4. PubMed ID: 17445752
[TBL] [Abstract][Full Text] [Related]
9. Is irritable bowel syndrome more common in patients presenting with bacterial gastroenteritis? A community-based, case-control study.
Parry SD; Stansfield R; Jelley D; Gregory W; Phillips E; Barton JR; Welfare MR
Am J Gastroenterol; 2003 Feb; 98(2):327-31. PubMed ID: 12591050
[TBL] [Abstract][Full Text] [Related]
10. To "lump" or to "split" the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome?
Moss-Morris R; Spence M
Psychosom Med; 2006; 68(3):463-9. PubMed ID: 16738080
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a risk score for post-infectious irritable bowel syndrome.
Thabane M; Simunovic M; Akhtar-Danesh N; Marshall JK
Am J Gastroenterol; 2009 Sep; 104(9):2267-74. PubMed ID: 19568228
[TBL] [Abstract][Full Text] [Related]
12. Post-infectious irritable bowel syndrome in patients with Shigella infection.
Ji S; Park H; Lee D; Song YK; Choi JP; Lee SI
J Gastroenterol Hepatol; 2005 Mar; 20(3):381-6. PubMed ID: 15740480
[TBL] [Abstract][Full Text] [Related]
13. Users of oral steroids are at a reduced risk of developing irritable bowel syndrome.
Huerta C; García Rodríguez LA; Wallander MA; Johansson S
Pharmacoepidemiol Drug Saf; 2003; 12(7):583-8. PubMed ID: 14558181
[TBL] [Abstract][Full Text] [Related]
14. The Incidence and gastrointestinal infectious risk of functional gastrointestinal disorders in a healthy US adult population.
Porter CK; Gormley R; Tribble DR; Cash BD; Riddle MS
Am J Gastroenterol; 2011 Jan; 106(1):130-8. PubMed ID: 20859264
[TBL] [Abstract][Full Text] [Related]
15. The incidence and risk factors of post-infectious irritable bowel syndrome: a meta-analysis.
Dai C; Jiang M
Hepatogastroenterology; 2012; 59(113):67-72. PubMed ID: 22024145
[TBL] [Abstract][Full Text] [Related]
16. Treatment of irritable bowel syndrome with colonic pacing: evaluation of pacing parameters required for correction of the "tachyarrhythmia" of the IBS.
Shafik A; Shafik AA; Ahmed I; el-Sibai O
Hepatogastroenterology; 2004; 51(60):1708-12. PubMed ID: 15532810
[TBL] [Abstract][Full Text] [Related]
17. Measuring the frequency of functional gastrointestinal disorders in rural Crete: a need for improving primary care physicians' diagnostic skills.
Lionis C; Olsen-Faresjo A; Anastasiou F; Wallander MA; Johansson S; Faresjo T
Rural Remote Health; 2005; 5(3):409. PubMed ID: 16108701
[TBL] [Abstract][Full Text] [Related]
18. Irritable bowel syndrome: a co-twin control analysis.
Wojczynski MK; North KE; Pedersen NL; Sullivan PF
Am J Gastroenterol; 2007 Oct; 102(10):2220-9. PubMed ID: 17897337
[TBL] [Abstract][Full Text] [Related]
19. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior.
Ford AC; Forman D; Bailey AG; Axon AT; Moayyedi P
Am J Gastroenterol; 2008 May; 103(5):1229-39; quiz 1240. PubMed ID: 18371141
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria.
Han SH; Lee OY; Bae SC; Lee SH; Chang YK; Yang SY; Yoon BC; Choi HS; Hahm JS; Lee MH; Lee DH; Kim TH
J Gastroenterol Hepatol; 2006 Nov; 21(11):1687-92. PubMed ID: 16984590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
